Related Experiment Video
Updated: May 5, 2026
09:43
Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
Published on: October 14, 2019
6.5K
Multiple endocrine neoplasia type 2A: a diagnostic challenge case report.
Abdulrahman Ahmad Othman1, Mohammad Alrzg2, Amina Bitar2
1Medizinische Fakultät der Universität des Saarlandes, Saarland, Germany.
Annals of Medicine and Surgery (2012)
|June 9, 2025
Summary
Multiple endocrine neoplasia type 2A (MEN2A) was diagnosed clinically in a patient due to resource limitations, avoiding genetic testing. This approach enabled timely treatment for pheochromocytoma, medullary thyroid cancer, and hyperparathyroidism, improving quality of life.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Multiple endocrine neoplasia type 2A (MEN2A) is a rare genetic disorder characterized by pheochromocytoma, medullary thyroid cancer, and hyperparathyroidism.
- Genetic testing is the standard diagnostic method, but resource constraints can necessitate alternative approaches.
Observation:
- A 28-year-old female presented with symptoms including hypertension, blurred vision, and sweating, suggestive of MEN2A.
- Diagnostic workup revealed adrenal tumors, medullary thyroid cancer, and hyperparathyroidism.
- Clinical findings alone were sufficient for diagnosis, bypassing genetic testing due to financial limitations.
Findings:
- The patient was diagnosed with MEN2A based on clinical presentation and laboratory/imaging findings.
- Treatment was initiated, leading to an improved quality of life with resolution of symptoms like headaches and palpitations.
Implications:
- This case highlights the importance of clinical diagnostic criteria for MEN2A in resource-limited settings.
- Effective management of MEN2A is achievable even without genetic testing, improving patient outcomes and quality of life.
Related Concept Videos
01:19Cushing Syndrome II: Pathophysiology
24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28